Taha Koray Sahin, Medical Oncologist at Hacettepe University, shared a post on X:
“Our latest study is now out in Immunotherapy!
The albumin–myosteatosis gauge (AMG) is an independent prognostic biomarker in ICI-treated patients
Low AMG is associated with shorter PFS and OS
A practical, accessible, and promising biomarker
Title: Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors
Authors: Taha Koray Sahin, Deniz Can Guven, Yakup Ozbay, Firat Atak, Sevtap Arslan, Mehmet Cihan İcli, Latif Karahan, Yunus Kaygusuz, Zafer Arik, Omer Dizdar, Mustafa Erman, Suayib Yalcin, Mehmet Ruhi Onur, Sercan Aksoy
You can read the Full Article on Immunotherapy
More posts featuring Immune checkpoint inhibitors.
